Literature DB >> 30108952

Revisiting amino acids and peptides as anti-glycation agents.

H Chilukuri1,2, M J Kulkarni2,3, M Fernandes1,2.   

Abstract

The importance of controlling or preventing protein glycation cannot be overstated and is of prime importance in the treatment of diabetes and associated complications including Alzheimer's disease, cataracts, atherosclerosis, kidney aliments among others. In this respect, simple molecules such as amino acids and peptides hold much promise both in terms of ease and scale-up of synthesis as well as in relation to negligible/low associated toxicity. In view of this, a comprehensive account of literature reports is presented, that documents the anti-glycation activity of natural and non-natural amino acids and peptides. This review also discusses the chemical reactions involved in glycation and the formation of advanced glycation end-products (AGEs) and possible/probable intervention sites and mechanism of action of the reported amino acids/peptides. This aspect of amino acids/peptides adds to their growing importance in medicinal and therapeutic applications.

Entities:  

Year:  2018        PMID: 30108952      PMCID: PMC6071831          DOI: 10.1039/c7md00514h

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  93 in total

1.  Decreased glycation and structural protection properties of γ-glutamyl-S-allyl-cysteine peptide isolated from fresh garlic scales (Allium sativum L.).

Authors:  Dehong Tan; Yao Zhang; Lulu Chen; Ling Liu; Xuan Zhang; Zhaoxia Wu; Bing Bai; Shujuan Ji
Journal:  Nat Prod Res       Date:  2015-01-29       Impact factor: 2.861

2.  A novel insulin receptor-binding protein from Momordica charantia enhances glucose uptake and glucose clearance in vitro and in vivo through triggering insulin receptor signaling pathway.

Authors:  Hsin-Yi Lo; Tin-Yun Ho; Chia-Cheng Li; Jaw-Chyun Chen; Jau-Jin Liu; Chien-Yun Hsiang
Journal:  J Agric Food Chem       Date:  2014-08-29       Impact factor: 5.279

3.  Momordica charantia and its novel polypeptide regulate glucose homeostasis in mice via binding to insulin receptor.

Authors:  Hsin-Yi Lo; Tin-Yun Ho; Chingju Lin; Chia-Cheng Li; Chien-Yun Hsiang
Journal:  J Agric Food Chem       Date:  2013-02-27       Impact factor: 5.279

4.  Elucidation of hypoglycemic action and toxicity studies of insulin-like protein from Costus igneus.

Authors:  Manasi R Hardikar; Mokshada E Varma; Anjali A Kulkarni; Prasad P Kulkarni; Bimba N Joshi
Journal:  Phytochemistry       Date:  2016-02-04       Impact factor: 4.072

5.  Orally active hypoglycemic protein from Costus igneus N. E. Br.: an in vitro and in vivo study.

Authors:  Bimba N Joshi; Hitendra Munot; Manasi Hardikar; Anjali A Kulkarni
Journal:  Biochem Biophys Res Commun       Date:  2013-06-04       Impact factor: 3.575

6.  Replacement of the CysA7-CysB7 disulfide bond with a 1,2,3-triazole linker causes unfolding in insulin glargine.

Authors:  Geoffrey M Williams; Kathryn Lee; Xun Li; Garth J S Cooper; Margaret A Brimble
Journal:  Org Biomol Chem       Date:  2015-04-07       Impact factor: 3.876

7.  Design, synthesis and biological evaluation of novel peptide MC2 analogues from Momordica charantia as potential anti-diabetic agents.

Authors:  Baowei Yang; Xue Li; Chenyu Zhang; Sijia Yan; Wei Wei; Xuekun Wang; Xin Deng; Hai Qian; Haiyan Lin; Wenlong Huang
Journal:  Org Biomol Chem       Date:  2015-04-21       Impact factor: 3.876

8.  Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs.

Authors:  Su Young Chae; Cheng-Hao Jin; Jae Hee Shin; Sohee Son; Tae Hyung Kim; Seulki Lee; Yu Seok Youn; Youngro Byun; Myung-Shik Lee; Kang Choon Lee
Journal:  J Control Release       Date:  2009-11-10       Impact factor: 9.776

9.  D-lysine effectively decreases the non-enzymic glycation of proteins in vitro.

Authors:  M Sensi; F Pricci; M G De Rossi; S Morano; U Di Marlo
Journal:  Clin Chem       Date:  1989-03       Impact factor: 8.327

10.  Design, synthesis, and biological activity of novel dicoumarol glucagon-like peptide 1 conjugates.

Authors:  Jing Han; Lidan Sun; Yingying Chu; Zheng Li; Dandan Huang; Xiaoyun Zhu; Hai Qian; Wenlong Huang
Journal:  J Med Chem       Date:  2013-12-13       Impact factor: 7.446

View more
  4 in total

1.  Zinc enhances carnosine inhibitory effect against structural and functional age-related protein alterations in an albumin glycoxidation model.

Authors:  Hichem Moulahoum; Faezeh Ghorbanizamani; Suna Timur; Figen Zihnioglu
Journal:  Biometals       Date:  2020-09-30       Impact factor: 2.949

Review 2.  The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.

Authors:  Chieh-Yu Shen; Cheng-Hsun Lu; Cheng-Han Wu; Ko-Jen Li; Yu-Min Kuo; Song-Chou Hsieh; Chia-Li Yu
Journal:  Molecules       Date:  2020-11-27       Impact factor: 4.411

Review 3.  The Potential Use of Carnosine in Diabetes and Other Afflictions Reported in Long COVID Patients.

Authors:  Fabiola Cardoso Diniz; Alan Roger Hipkiss; Gustavo Costa Ferreira
Journal:  Front Neurosci       Date:  2022-06-22       Impact factor: 5.152

4.  In Vitro Antioxidant and Antiaging Activities of Collagen and Its Hydrolysate from Mackerel Scad Skin (Decapterus macarellus).

Authors:  Elisa Herawati; Yochidamai Akhsanitaqwim; Pipin Agnesia; Shanti Listyawati; Artini Pangastuti; Adi Ratriyanto
Journal:  Mar Drugs       Date:  2022-08-13       Impact factor: 6.085

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.